Article info
PDFInflammatory bowel disease
Therapeutic potency of IL2–caspase 3 targeted treatment in a murine experimental model of inflammatory bowel disease
- Dr H Lorberboum-Galski, Department of Cellular Biochemistry and Human Genetics, Hebrew University, Faculty of Medicine, Jerusalem 91120, Israel; hayag{at}ekmd.huji.ac.il
Citation
Therapeutic potency of IL2–caspase 3 targeted treatment in a murine experimental model of inflammatory bowel disease
Publication history
- Revised September 15, 2008
- Accepted October 14, 2008
- First published October 31, 2008.
Online issue publication
May 11, 2009
Article Versions
- Previous version (31 October 2008).
- Previous version (4 November 2008).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
2009 BMJ Publishing Group and British Society of Gastroenterology